Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.86EUR
−74.38 MEUR
293.55 KEUR
80.07 M
About Chimerix, Inc.
Sector
CEO
Michael T. Andriole
Headquarters
Durham
Website
Employees (FY)
72
Founded
2000
FIGI
BBG004FSD6X9
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CXF is 0.90 EUR — it has increased by 1.70% in the past 24 hours. Watch CHIMERIX INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange CHIMERIX INC stocks are traded under the ticker CXF.
CXF stock has risen by 2.52% compared to the previous week, the month change is a 2.87% rise, over the last year CHIMERIX INC has showed a 30.38% decrease.
We've gathered analysts' opinions on CHIMERIX INC future price: according to them, CXF price has a max estimate of 10.40 EUR and a min estimate of 4.73 EUR. Watch CXF chart and read a more detailed CHIMERIX INC stock forecast: see what analysts think of CHIMERIX INC and suggest that you do with its stocks.
CXF stock is 2.50% volatile and has beta coefficient of 0.93. Track CHIMERIX INC stock price on the chart and check out the list of the most volatile stocks — is CHIMERIX INC there?
Today CHIMERIX INC has the market capitalization of 79.99 M, it has decreased by 2.26% over the last week.
Yes, you can track CHIMERIX INC financials in yearly and quarterly reports right on TradingView.
CHIMERIX INC is going to release the next earnings report on Aug 7, 2024. Keep track of upcoming events with our Earnings Calendar.
CXF earnings for the last quarter are −0.23 EUR per share, whereas the estimation was −0.20 EUR resulting in a −13.72% surprise. The estimated earnings for the next quarter are −0.22 EUR per share. See more details about CHIMERIX INC earnings.
CHIMERIX INC revenue for the last quarter amounts to 0 EUR despite the estimated figure of 288.97 K EUR. In the next quarter revenue is expected to reach 288.00 K EUR.
CXF net income for the last quarter is −20.27 M EUR, while the quarter before that showed −16.45 M EUR of net income which accounts for −23.18% change. Track more CHIMERIX INC financial stats to get the full picture.
No, CXF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 1, 2024, the company has 72.00 employees. See our rating of the largest employees — is CHIMERIX INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHIMERIX INC EBITDA is −86.41 M EUR, and current EBITDA margin is −28.72 K%. See more stats in CHIMERIX INC financial statements.
Like other stocks, CXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHIMERIX INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHIMERIX INC technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHIMERIX INC stock shows the sell signal. See more of CHIMERIX INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.